ETTX
Entasis Therapeutics Holdings Inc

2,122
Loading...
Loading...
Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Entasis Therapeutics Holdings Inc?
What is the 52-week high for Entasis Therapeutics Holdings Inc?
What is the 52-week low for Entasis Therapeutics Holdings Inc?
What is Entasis Therapeutics Holdings Inc stock price today?
What was Entasis Therapeutics Holdings Inc stock price yesterday?
What is the PE ratio of Entasis Therapeutics Holdings Inc?
What is the Price-to-Book ratio of Entasis Therapeutics Holdings Inc?
What is the 50-day moving average of Entasis Therapeutics Holdings Inc?

Latest ETTX News

View
No ETTX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.